H.R. 5133 · 116th Congress

Affordable Prescriptions for Patients Through Promoting Competition Act of 2019

Stage: Reported from committee
Sponsor: David Cicilline
Introduced: 2019-11-18
Latest action: 2020-12-24 · Reported by the Committee on Judiciary. H. Rept. 116-695.

Subjects

Health care costs and insurance

Civil actions and liability

Inflation and prices

Commerce

Consumer affairs

Intellectual property

Prescription drugs

Competition and antitrust

Drug safety, medical device, and laboratory regulation

Manufacturing

Administrative remedies

Judicial review and appeals

Federal Trade Commission (FTC)